BioMedomics, Inc. is proud to announce its ISO 13485:2016 certificate has expanded in scope to include the design, development and manufacturing of COVID-19 rapid tests.
We are excited to announce that the National Institute for Food and Drug Surveillance (INVIMA) has given BioMedomics, Inc. authorization to sell and distribute our
We are excited to announce that the Therapeutic Goods Administration, a branch of the Department of Health in the Australian Government, has given BioMedomics, Inc.
We are excited to announce that the Tanzania Medicines and Medical Devices Authority has given authorization to BioMedomics, Inc. to sell and distribute our world-renown
BioMedomics is the first company to publish a journal article about the development and launch of a rapid COVID-19 test. You can also refer to
BioMedomics™ Participates in Free Sickle Cell Screening Events Using Sickle SCAN® Rapid Test During MEA Rugby Championship
Morrisville, NC, USA – BioMedomics, a leader in innovative clinical diagnostics products that address global healthcare needs, participated in several sickle cell screening events in
BioMedomics™ Introduces Nigerian Rugby Player Ade Adebisi as Brand Ambassador for Sickle SCAN® Product
Morrisville, NC, USA – BioMedomics, a leader in innovative clinical diagnostics products that address global healthcare needs, proudly announced a partnership today with Ade Adebisi,
Publisher Wiley-Blackwell released a new book in May entitled “Revolutionizing Tropical Medicine: Point-of-Care Tests, New Imaging Technologies and Digital Health” by authors/editors Kerry Atkinson and
BioMedomics Sickle SCAN Rapid Test Evaluated Under Real-World Conditions in Africa: the DREPATEST Study
A study published this month in the journal BMC Hematology, evaluated the performance of BioMedomics’ Sickle SCAN rapid test under real-world environmental conditions in two